Technology News and Research

RSS

Boston Scientific announces positive results from REPRISE II clinical trial of Lotus Valve System

Boston Scientific Corporation reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus™ Valve System in symptomatic patients with severe aortic stenosis considered at high risk for surgical valve replacement.

17 Sep 2013

Using Serialization to Prevent Counterfeiting in the Pharmaceutical Industry

News-Medical speaks to Sue Miles about the dangers of counterfeit pharmaceutical products and how PCI are reducing the risk of counterfeiting during transit.

From Packaging Coordinators Inc. (PCI) 17 Sep 2013

Innovative sodium reduction and fiber ingredients showcased at 20th International Congress of Nutrition

Backed by research that demonstrates significant health benefits as well as unparalleled taste that meets consumer needs, food ingredients are taking center stage as thousands of experts from around the world converge to discuss the state of global health and nutrition at the leading international nutrition conference taking place this week in Spain.

17 Sep 2013

LSO Medical, GME German Medical Engineering form strategic partnership

LSO Medical SAS, a leading French laser manufacturer for aesthetic and surgical applications, and GME German Medical Engineering GmbH, a German company developing and marketing laser applications, announced today the formation of a strategic partnership.

17 Sep 2013

Flecainide, encainide drugs increase risk of sudden cardiac death

Scientists have discovered that a drug which increases the risk of sudden cardiac death interacts with mistranslated protein-coding genes present in heart muscle.

17 Sep 2013

Researchers develop new variety of corked microbottle for drugs

Sustained-release formulations that release drugs over longer periods of time are not the final step in the evolution of “intelligent” drug delivery systems. Modern pharmaceuticals are being designed to be released only in a specific, diseased organ; on cues from our circadian rhythm; or under specific physiological conditions.

17 Sep 2013

NJIT student team to develop innovative interactive toys for autistic children

NJIT Distinguished Professor Atam P. Dhawan, PhD, recently joined the autism community at the NJ State House to be recognized for improving public and private autism services.

17 Sep 2013

Final countdown on for health exchange launches

Federal officials are happy with what may turn out to be a soft launch of the health law's insurance exchanges Oct. 1. In the meantime, states are busy readying consumers for the exchanges' kickoffs with informational sessions and campaigns designed at creating a better-informed public.

17 Sep 2013

Studying Tumor Mutations Via A Network Approach

...

16 Sep 2013

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

...

16 Sep 2013

Bruker Launches Second Phase Of SISCAPA-MALDI Collaboration

After focusing on confirming the utility and quantitative precision of the SISCAPA-MALDI workflow in the collaboration's first phase, Bruker said it plans to establish fully automated SISCAPA-MALDI capabilities in its demonstration facilities.

16 Sep 2013

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute radiation syndrome (ARS).

16 Sep 2013

Bangkok Hospital Group selects Elsevier's ClinicalKey to support clinical decision-making

Elsevier's flagship 'clinical insight engine' provides fast, comprehensive and trusted medical content and answers to more than 500 clinicians.

16 Sep 2013

ChipCare’s handheld analyzer secures largest investments in Canada's healthcare sector

An innovative, handheld point-of-care analyzer, developed by ChipCare Corporation, has secured one of the largest ever angel investments in Canada's healthcare sector. Phase II financing has closed, with an investment of $2.05M to support ChipCare's continuing development and commercialization over the next three years.

16 Sep 2013

LifeSensors receives U.S. patent for development of novel DUB substrates

LifeSensors, Inc., a biotech company developing cutting-edge technologies for studying the ubiquitin pathway, has been awarded a U.S. patent for the development of novel, fluorescent di- and poly-ubiquitin deubiquitinase substrates (US 8,518,660).

16 Sep 2013

Climate change not likely to make malaria situation worse in West Africa, say researchers

As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.

16 Sep 2013